Effects of estrogen replacement therapy on thrombin generation.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Thrombosis Research

• Publication date

  1997-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0049-3848(97)00003-0PMID 9058493
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cyclic hormonal replacement therapy after the menopause: Transdermal versus oral treatment

  2004cited by this paper
• Effect of transdermal oestradiol on the haemostatic balance of menopausal women.

  1993cited by this paper
• Measurement of beta-thromboglobulin and platelet factor 4 to follow up patients with artificial heart valves.

  1993cited by this paper
• The Effect of Estrogen Replacement Therapy on Platelet Aggregation and Adenosine Triphosphate Release in Postmenopausal Women

  1993cited by this paper
• Cardiovascular protection by oestrogen--a calcium antagonist effect?

  1993cited by this paper
• Acute effect of 17 beta-estradiol on rabbit coronary artery contractile responses to endothelin-1.

  1992cited by this paper
• Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implications for atherosclerosis.

  1992cited by this paper
• Coagulation Activation Following Estrogen Administration to Postmenopausal Women

  1992cited by this paper
• Short- and long-term effects of hormone replacement therapy (transdermal estradiol vs oral conjugated equine estrogens, combined with medroxyprogesterone acetate) on blood coagulation factors in postmenopausal women.

  1991cited by this paper
• Short- and long-term effects of hormone replacement therapy (transdermal estradiol vs oral conjugated equine estrogens, combined with medroxyprogesterone acetate) on blood coagulation factors in posimenopausal women

  1991cited by this paper
• Transdermal estradiol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of menopausal complaints.

  1991cited by this paper
• Effects of long-term gestodene-containing oral contraceptive administration on hemostasis.

  1990cited by this paper
• Mortality among oral contraceptive users: 20 year follow up of women in a cohort study.

  1989cited by this paper
• The use of hormonal replacement therapy and the risk of stroke and myocardial infarction in women.

  1989cited by this paper
• Decreased in vitro production of 6‐keto‐prostaglandin F(1α) by uterine arteries from postmenopausal women

  1989cited by this paper
• A prospective study of past use of oral contraceptive agents and risk of cardiovascular diseases.

  1989cited by this paper
• A Prospective Study of Past Use of Oral Contraceptive Agents and Risk of Cardiovascular Diseases

  1988cited by this paper
• Determination of Human Thrombin-Antithrombin III Complex in Plasma with an Enzyme-Linked Immunosorbent Assay

  1988cited by this paper
• Blood coagulation in postmenopausal women given estrogen treatment: comparison of transdermal and oral administration.

  1988cited by this paper
• Risk factors for myocardial infarction in young women.

  1987cited by this paper
• Evaluation of factor VII antigen in factor VII congenital deficiencies with a new ELISA assay

  1987cited by this paper
• Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study.

  1987cited by this paper
• Menopause and the risk of coronary heart disease in women.

  1987cited by this paper
• Biologic effects of transdermal estradiol

  1986cited by this paper
• Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. The Framingham Study.

  1985cited by this paper
• The Use of a Functional and Immunologic Assay for Plasma Protein C in the Study of the Heterogeneity of Congenital Protein C Deficiency

  1984cited by this paper
• Vasoconstrictory thromboxane A2 and vasodilatory prostacyclin in climacteric women: effect of oestrogen-progestogen therapy.

  1984cited by this paper
• New separation method for monoclonal immunoradiometric assays and its application to assays for thyrotropin and human choriogonadotropin.

  1984cited by this paper
• Comparison of antithrombin III assays using biological and chromogenic substrates

  1982cited by this paper
• Synthetic Oligopeptide Substrates Their Diagnostic Application in Blood Coagulation, Fibrinolysis, and Other Pathologic States

  1980cited by this paper
• A solid phase immuno enzymological assay for the measurement of human fibrinopeptide A.

  1980cited by this paper
• Recent trends in methodological simplification of steroid radioimmunoassay.

  1978cited by this paper
• Menopause and risk of cardiovascular disease: the Framingham study.

  1977cited by this paper
• Menopause and Risk of Cardiovascular Disease: The Framingham Study

  1976cited by this paper
• Risk factors for myocardial infarction in young women.

  1976cited by this paper
• A laboratory manual of blood coagulation

  1975cited by this paper
• Estimation of the activator of fibrinolysis by means of the euglobulin test.

  1965cited by this paper

• Risk factors for neurological complications in adult ECMO patients: a systematic review and meta-analysis.

  2026cites this paper
• Global coagulation assays in healthy controls: are there compensatory mechanisms within the coagulation system?

  2021cites this paper
• Establishment of normal reference range for thromboelastography based on 17,708 cases in Beijing, China

  2021cites this paper
• Plasma fibrin clot properties in postmenopausal women: effects of hormone therapy

  2016cites this paper
• Fertility control Heparanase procoagulant activity is elevated in women using oral contraceptives

  2013cites this paper
• Heparanase procoagulant activity is elevated in women using oral contraceptives.

  2013cites this paper
• A importância da via de administração na terapia hormonal do climatério

  2010cites this paper
• The effect of transdermal estradiol or oral conjugated oestrogen and fenretinide versus placebo on haemostasis and cardiovascular risk biomarkers in a randomized breast cancer chemoprevention trial

  2008cites this paper
• Effects of non-oral postmenopausal hormone therapy on markers of cardiovascular risk: a systematic review.

  2008cites this paper
• Inflammation and haemostasis in the development and progression of peripheral atherosclerotic disease

  2007cites this paper
• The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women

  2006cites this paper
• Effect of Pulsed Estrogen Therapy on Hemostatic Markers in Comparison with Oral Estrogen Regimen in Postmenopausal Women

  2006cites this paper
• Anticoagulation effect of estroprogesterone therapy in women in menopausal period

  2005cites this paper
• Double blind, randomized study of estradiol replacement therapy on markers of inflammation, coagulation and fibrinolysis.

  2003cites this paper
• A randomized, placebo-controlled trial of the effects of continuous combined hormone replacement therapy on coagulation and fibrinolytic systems in healthy postmenopausal women.

  2002cites this paper
• The effects of postmenopausal hormone replacement therapy on hemostatic variables: a meta-analysis of 46 studies

  2002cites this paper
• Oral contraceptive pills and hormonal replacement therapy and thromboembolic disease.

  2000cites this paper
• The effects of hormone replacement therapy on thrombin generation, fibrinolysis inhibition, and resistance to activated protein C: prospective cohort study and review of literature.

  2000cites this paper
• Phytoestrogens and cardiovascular health.

  2000cites this paper
• Postmenopausal hormone replacement therapy increases coagulation activity and fibrinolysis.

  2000cites this paper
• The role of hormone replacement therapy in preventing coronary artery disease in women.

  1998cites this paper
• Women's Health LiteratureWatch & Commentary

  1997cites this paper